Presented by the UCSF Department of Laboratory Medicine and UCSF Center for Research in Transfusion Medicine and Cellular Therapies
Discussion and talks will focus upon funding, translation, cell product production and processing
Badge and Materials Pickup
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Discussion will focus upon funding support for the translational pipeline which includes the infrastructure needed for pre-clinical and clinical trials in trauma and critical care. Funding from federal sources, industry, philanthropy and venture capital will be discussed. Panelists will include representation from the NIH, BARDA, DOD, industry stakeholders and a venture capital firm.
Moderator(s)Executive Director, Infectious Disease Research Center
Office of the Vice President for Research
Professor, Department of Microbiology, Immunology and Pathology,
Colorado State University
COL, USA, Ret.
Chief Executive Officer at SunQ, LLC
Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office
Director, Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
VP of Regulatory for Cellular Therapies
CSSi LifeSciences
Chief United States Radiological and Nuclear Countermeasures, Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority (BARDA)
Vice President & Director of Launchpad
Colorado State University Ventures
Lieutenant Colonel, US Army (Retired)
Health Science Program Manager
Hemorrhage and Resuscitation/Forward Surgical Care/Blood Products// Congressionally Directed Medical Research Program (CDMRP) US Army Medical Research and Development Command (MRDC)
Discussion will focus upon the translational barriers and challenges that exist in cell product production, development and processing. Panelists will include representation from the private industry, blood banks, NIH and academic centers involved in this space.
Moderator(s)Professor of Transfusion Medicine
Director of the Division of Transfusion Medicine
University of Minnesota
Director for Center for Cellular Engineering, NIH Clinical Center
Medical Director, UCSF HICTF and GMP Facility
Medical Director, Zuckerberg San Francisco General Hospital Blood Bank and Transfusion Service
Assistant Adjunct Professor, UCSF, Dept. of Laboratory Medicine
Co-Chair CTTACC
COL, USA, Ret.
Professor of Regenerative Medicine
Wake Forest University
Sr. Vice President, Chief Operating Officer, GenCure
Associate Professor of Clinical and Translational Sciences
Director, Cellular Therapy Core
Department of Pediatric Surgery
McGovern Medical School at UTHealth
Chief Executive & Technology Officer, RoosterBio, Inc.
Director, Regenerative Medicine Clinical Center
Wake Forest Institute for Regenerative Medicine
Vice President, Corporate Development
OrganaBio, LLC
Vice President, Regenerative Medicine
Head of Neurosciences, Athersys, Inc.
Discussion will focus upon the current successes and challenges that exist in finalizing the end of product development which includes optimal cryopreservation, storage, shipping, handling and delivery of the final product to patients. These are areas that are critical for the success and safety of the products, clinical trials and final patient outcomes. Panelists will include representation from the private industry, blood banks and academic centers involved in this space.
Moderator(s)Senior VP & CTO
BioLife Solutions
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Chief Scientific Officer & Co-Founder of Personalized Stem Cells, Inc.
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
McGovern Medical School at UTHealth
M SGT, USA, Ret.
President Combat Medical
Professor of Transfusion Medicine
Director of the Division of Transfusion Medicine
University of Minnesota
President & CEO
Hope Biosciences
Associate Professor of Clinical and Translational Sciences
Director, Cellular Therapy Core
Department of Pediatric Surgery
McGovern Medical School at UTHealth
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
COL, USA, Ret.
Chief Executive Officer at SunQ, LLC
Ex Director and Founder of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office
The goal of this session is to discuss and understand pertinent issues in transfusion medicine and novel blood products related to the bleeding and acutely injured trauma patient. Topics of discussion will focus around novel blood products and adjuncts to resuscitation in bleeding patients.
Badge and Materials Pickup
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Senior Director, Division of Transfusion Medicine
Professor of Pathology
Johns Hopkins University
Professor of Pediatrics
Washington Univ School of Medicine St. Louis
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
Col, USAF MC
Joint Trauma System, Chief
DHA Combat Support
Professor of Surgery and Critical Care
Director of Acute Care Surgery Fellowship
University of Pittsburgh
COL, USAF, Ret.
Professor of Surgery Uniformed Services University
Professor/Clinical, Division of Trauma and Emergency Surgery
Vice Chair for Quality, Department of Surgery UT San Antonio
Betty and Bob Kelso Distinguished Chair in Burn and Trauma Surgery
–
Visit Exhibits
Roberta G. Simmons Assistant Professor of Surgery
Assistant Professor of Clinical and Translational Science and Critical Care Medicine
University of Pittsburgh
SME Blood Products
USAMRMC
Norman W. Thompson Professor of Surgery
Section Head of General Surgery
University of Michigan
Professor of Surgery
Vice Chair of Research
Editor of Journal of Trauma and Acute Care Surgery
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
Co-Chair CTTACC
CAPT, USN, Ret.
Professor of Surgery
Maine Medical Center Tufts University
Professor of Trauma Sciences
Queen Mary University of London
Director London Major Trauma System
Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC
Co-Chair CTTACC
CAPT, USN, Ret.
Professor of Surgery
Maine Medical Center Tufts University
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
COL, USA
Professor of Medicine
Uniformed Services University of the Health Sciences
Chief, Blood Research Program
US Army Institute for Surgical Research
President AABB
Chief Medical and Scientific Officer
Senior Vice President at New York Blood Center
Professor of Transfusion Medicine and Cell Therapy
French Military Blood Institute Clamart
Professor of Surgery
Vice Chair of Research
Editor of Journal of Trauma and Acute Care Surgery
Professor of Surgery and Critical Care
Director of Acute Care Surgery Fellowship
University of Pittsburgh
Professor of Trauma Sciences
Queen Mary University of London
Director London Major Trauma System
Visit Exhibits
Emeritus Professor,
University of Minnesota
Professor Emeritus
University of California, San Francisco
Professor of Surgery
Director of Translational Research Shock Trauma
University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center
Senior VP and Chief Scientific Officer Cerus Inc.
Professor of Pediatrics, Biochemistry and Bioengineering
Director, Center for Blood Oxygen Transport and Hemostasis
University of Maryland School of Medicine
President AABB
Chief Medical and Scientific Officer
Senior Vice President at New York Blood Center
Visit Exhibits
Chief Medical Research Officer
Associate Director, Research
Translational Medicine Institute
Colorado State University
Assistant Professor of Surgery
Trauma Surgery and Surgical Critical Care
University of California San Francisco
Zuckerberg San Francisco General Hospital
COL, USA, Ret.
President & Director of Research and Development, Cellphire Inc.
Professor of Trauma Sciences
Queen Mary University of London
Director London Major Trauma System
COL, USA
Professor of Medicine
Uniformed Services University of the Health Sciences
Chief, Blood Research Program
US Army Institute for Surgical Research
Professor and Chair of Department of Biomedical Engineering
Professor of Department of Cell & Development Biology
Oregon Health & Science University
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Research Professor
Department of Laboratory Medicine, UCSF
Professor of Pediatrics
Washington Univ School of Medicine St. Louis
Discussion will focus upon the current successes, challenges and translational barriers that exist in the development of novel blood products. Including dried plasma, dried platelets, dried cryoprecipitate, and more.
Moderator(s)Co-Chair CTTACC
COL, USA, Ret.
Professor of Regenerative Medicine
Wake Forest University
COL, USA, Ret.
President and CEO
Richblo2d Biologics Consulting Services LLC
COL, USA
Professor of Medicine
Uniformed Services University of the Health Sciences
Chief, Blood Research Program
US Army Institute for Surgical Research
Senior VP and Chief Scientific Officer Cerus Inc.
Chief Medical Officer
Velico Medical, Inc
COL, USA, Ret.
President & Director of Research and Development, Cellphire Inc.
Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Lieutenant Colonel, US Army (Retired)
Health Science Program Manager
Hemorrhage and Resuscitation/Forward Surgical Care/Blood Products// Congressionally Directed Medical Research Program (CDMRP) US Army Medical Research and Development Command (MRDC)
Chief Executive Officer, Hemoglobin Oxygen Therapeutics LLC
The goal of this session is to discuss and learn about the state of the science of cellular therapies in trauma and critical care. Pre-clinical and clinical studies will be presented in traumatic brain injury (TBI), Spinal Cord Injury (SCI), acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), cardiac disease, wound healing and tissue and bone regeneration.
Badge and Materials Pickup
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
McGovern Medical School at UTHealth
Associate Professor in the Department of Medicine, University of Ottawa
Senior Scientist with the Clinical Epidemiology Department of the Ottawa Hospital Research Institute
Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD
Professor of Medicine & Radiology Stanford University School of Medicine
Professor of Surgery
Chair, Department of Urology
Director, Wake Forest Institute for Regenerative Medicine at Wake Forest University
Professor of Pulmonary Critical Care Medicine
Associate Director of ICU
University of California San Francisco
Professor of Medicine
University of Vermont
ISCT Chief Scientific Officer
Vice President, Regenerative Medicine
Head of Neurosciences, Athersys, Inc.
Visit Exhibits
Professor and Chief of Surgery
Zuckerberg San Francisco General,
Vice Chair of Trauma and Critical Care Surgery
UCSF Department of Surgery
Norman W. Thompson Professor of Surgery
Section Head of General Surgery
University of Michigan
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
McGovern Medical School at UTHealth
Assistant Professor of Neurosciences
Center for Neural Repair
University of California San Diego
Senior Resident in Neurosurgery
University of California San Diego
Health Scientist
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures (DBRN)
Biomedical Advanced Research and Development Authority (BARDA)
Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Visit Exhibits
Director, Stem Cell Program and Institute for Regenerative Cures
University of California Davis Health
Scientific Director, UC Davis GMP Facility
Editor-in-Chief, Stem Cells
Acute Care Surgery Fellow
Wake Forest Baptist Medical Center
Professor and Distinguished Chairman Department of Laboratory Medicine, UCSF
Director, Stem Cell Program and Institute for Regenerative Cures
University of California Davis Health
Scientific Director, UC Davis GMP Facility
Editor-in-Chief, Stem Cells
Assistant Professor of Medicine
Co Director Translational Investigator Program
Stanford University
Professor of Transfusion Medicine and Cell Therapy
French Military Blood Institute Clamart
Visit Exhibits
Professor of Pulmonary Critical Care Medicine
Associate Director of ICU
University of California San Francisco
VP of Manufacturing Sciences, Platelet BioGenesis
Chief Scientific Officer
Miltenyi Biotec
Associate Professor, Biomedical Engineering, Rutgers University
Division Leader, Center for Surgery, Innovation, and Bioengineering, Harvard Medical School and Massachusetts General Hospital
Affiliated Faculty, Harvard Stem Cell Institute and the Broad Institute for Genetics
Co-Founder, Director, and Office of Chief Scientific Officer, Sentien Biotechnologies, Inc.
CTTACC Conference Co-Chair
COL, USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
CTTACC Conference Chair
Professor of Laboratory Medicine, UCSF
Scientific Director of Cellular Therapies
Questions? Email us at [email protected] or call 303-238-0685